An interventional study of Kinesiology Tape in Carpal Tunnel Syndrome, sponsored by University of Nevada, Las Vegas. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-03.
Sponsored by University of Nevada, Las Vegas · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies in Carpal Tunnel Syndrome with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Carpal Tunnel Syndrome · United States.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, this one is the 48th largest by planned enrollment of the 72 interventional ones that give a count, is one of 3 that started in 2025, is one of 47 with no phase, reaches primary completion later than 1 of the 11 other live ones, and was the 92nd registered.
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
Browse Carpal Tunnel Syndrome studies →10 of the 97 studies in Carpal Tunnel Syndrome with a site in United States are open now. Recruiting first, the newest first:
New York Institute of Technology · Sites in United States
Ages 18+
University of Arizona · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18+
Extremity Medical · Sites in United States
Ages 18–85
Spaulding Rehabilitation Hospital · Sites in United States
Ages 18–80
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 11 · Phase 3 2 · Phase 4 10
First in 1997; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 60 across 446 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 50 across the 72 interventional studies, 107 across the 24 observational. Of the 68 that completed or were terminated, 16 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 97 have an industry lead sponsor. The 10 most frequent:
University of Nevada, Las Vegas is the lead sponsor of 75 studies on the registry; 22 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.
University of Nevada, Las Vegas has 2 studies filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Carpal Tunnel Syndrome with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04804293Mayo ClinicAssessment of Carpal Tunnel Syndrome by Shearwave Elastography | 2026-12-20 |
| NCT07158892University of Texas at AustinUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | 2027-01-20 |
| NCT06907849University of Tennessee Graduate School of Medicine124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome | 2027-03 |
| NCT04206215Spaulding Rehabilitation HospitalNoninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome | 2027-07-02 |
Add all 4 to your calendar (.ics) → With an account.
Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if dorsally applied kinesiology tape is an effective conservative treatment for symptoms of carpal tunnel syndrome and assess the potential performance effect of the tape color in first-person shooter esports games in esports gamers who exhibit symptoms that resemble carpal tunnel syndrome. The main questions it aims to answer are:
Is dorsally applied kinesiology tape able to manage carpal tunnel syndrome-like symptoms in esports gamers? Does red kinesiology tape hinder or improve performance in first-person shooter esports games in esports gamers?
Researchers will compare red kinesiology tape to skin tone kinesiology tape. Both will be applied on the dorsal aspect of the hand and wrist of the dominant upper extremity.
Participants will visit the site 2 times to get kinesiology tape applied and complete a pre and post-test for pain and performance. Depending on randomization a participant will receive a random sequence of the study arm (ex: red then skin tone or skin tone then red tape)
Less Pain, More Game - Efficacy of Red Kinesiology Tape on Carpal Tunnel Symptoms and Performance in Esports Gamers is a clinical trial that aims to determine if dorsally applied kinesiology tape can manage or improve symptoms that resemble carpal tunnel syndrome in esports gamers. Esports gamers use their hands very differently from the average individual when participating in hours of video game play. This study first aims to test if kinesiology tape would benefit these individuals despite the frequency and intensity with which they use their hands and fingers.
Performance and competition is a major component of esports gaming participation. Despite how well kinesiology tape may improve symptoms of carpal tunnel syndrome, it would not be a good treatment option if it hindered their ability to participate in esports. This study also aims to address performance as well. Color has been identified as a quality of kinesiology tape that may impact performance. Thus this study also seeks to assess the potential performance effect of the tape color in first-person shooter esports games in esports gamers who exhibit symptoms that resemble carpal tunnel syndrome.
Participants will visit the site 2 times to get kinesiology tape applied and complete a pre and post-test for the Short Form Mcgill Pain Questionnaire and a first-person shooter simulation to assess performance. The study design is a randomized controlled crossover trial thus depending on randomization a participant will receive a random sequence of the study arm (ex: red then skin tone or skin tone then red tape).
Results from this study would allow occupational therapists to promote health and wellness within the esports gamer population and enhance performance to give players an edge over their opponents.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The red kinesiology tape will be applied with the dorsal application for carpal tunnel syndrome. It is explained and utilized in Krause et al. (2020). The color red has been found in previous studies to impact motor function and performance in various activities specifically when looking at activities of an aggressive or competitive nature. Thus red was chosen when assessing the color effect of red in first-person shooter games which require outperforming the opponent with quick reaction time, accuracy, and aggression. Each participant will receive the red KT application only once. The order of which they receive the red KT or the skin tone KT will depend on their random assignment to group X or Y. The KT will be applied by an interventionist trained in proper KT application. Participants will be educated on self-removal specifically given by the manufacturer of the brand of KT used (Sparthos Tape). There will be a 7 day washout period between tape applications.
Device: Kinesiology Tape
The skin tone kinesiology tape will be applied with the dorsal application for carpal tunnel syndrome. It is explained and utilized in Krause et al. (2020). Sparthos KT offers skin tone KT covering multiple shades to allow the closest color to match the participant's skin. Utilizing other skin tones other than beige allows inclusion and diversity. The skin tone KT was chosen to diminish the effect of the KT color to allow better isolation and study of the effect of the color red in comparison. Each participant will receive the skin tone KT application only once. The order in which they receive the red KT or the skin tone KT will depend on their random assignment to group X or Y. The KT will be applied by an interventionist trained in proper KT application. Participants will be educated on self-removal specifically given by the manufacturer of the brand of KT used (Sparthos Tape). There will be a 7 day washout period between tape applications.
Device: Kinesiology Tape
The kinesiology tape (KT) is applied with the dorsal application for the treatment of carpal tunnel syndrome (CTS). This method is utilized and explained in Krause et al. (2020). This study will assess the efficacy of the application method as well as the varying effects of the color of the KT. Red KT will be compared to skin tone KT. The skin tone KT will be color-matched as closely as possible to each participant's skin tone to reduce the effect of the KT color. In this way, the study's second purpose is to understand the potential effect of color on psychological function and performance in the context of aggressive first-person shooter esports games.
McGill Pain Questionnaire Short-Form
Short Form - McGill Pain Questionnaire - 2 will give outcomes of pain intensity and quality. It includes adjectives to describe both nociceptive pain and neuropathic pain. Pain descriptors can be categorized into Continuous (throbbing pain, cramping pain, gnawing pain, aching pain, heavy pain, tender), Intermittent (shooting pain, stabbing pain, sharp pain, splitting pain, electric-shock pain, piercing), Neuropathic (hot-burning pain, cold-freezing pain, pain caused by light touch, itching, tingling or "pins and needles", numbness), and Affective (tiring-exhausting, sickening, fearful, punishing-cruel) It will be taken 4 times by each participant: before the first application of the KT, after the first application of the KT, before the second application of the KT in the opposite color, and after the second application of the KT in the opposite color.
Time frame: at intervals throughout the 3 week cycle
3D Aim Trainer Attack Bombsite Simulation
It is an esports shooting simulation on easy difficulty and is completed on a Dell PC with a keyboard and mouse setup. It will measure performance through a collection of overall scores and accuracy percentages. The participants will have to shoot at enemy targets while dodging attacks and surviving to the next stage. Each stage of the simulation will increase in difficulty. The simulation will be completed with the computer set to a grayscale display to eliminate any effect of the colors of the original simulation. Each attempt of the simulation will end after 200 seconds. It will be completed in a private room with only the student researcher present. The simulation is free and can be found here: https://www.3daimtrainer.com/. Data from this simulation will be stored under the participant ID code on a protected Google Sheets document. It will be taken 4 times by each participant: before KT, after the KT, before the KT in the opposite color, and after KT in the opposite color.
Time frame: at intervals throughout the 3 week cycle
End of Study Survey
It is completed only once online after self-removal of the 2nd KT application. This survey will ask about how long the tape lasted before it lost adhesiveness, KT color preference, willingness to recommend KT to others, KT color effect on performance, and KT color effect on CTS symptoms. This will be completed anonymously on their own time as an additional component of the study to collect qualitative comments related to their experience with the KT. They will also be able to indicate their desire to learn how to self-apply KT. If they indicate an interest in self-application, they will be directed to email the student researcher.
Time frame: at the last visit of the 3-week study cycle
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Start is estimated for Jan 2025; primary completion for Mar 2025, 2 months later.
Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 2 months is below that.
Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Nevada, Las Vegas